The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

5 Oct 2018 07:00

RNS Number : 0529D
Ideagen PLC
05 October 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Directors' dealings

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces dealings by certain directors in Ideagen's ordinary shares of 1p each ("Ordinary Shares").

Graeme Spenceley, Barnaby Kent and Ben Dorks, executive directors (the "Exercising Directors"), have each exercised 600,000 options over Ordinary Shares (the "Options"). Each subsequently sold 300,000 Ordinary Shares at a price of 152 pence per Ordinary Share to cover the costs and tax arising on the exercise. These Options were awarded pursuant to the Group's 2017 Long Term Incentive Plan and the Board (excluding the Exercising Directors) used their discretion under the 2017 Long Term Incentive Plan to allow the early exercise of the Options and associated sale.

Each of the Exercising Directors have undertaken to the Board that they will not, without the permission of the Board (excluding each of the Exercising Directors), sell any of the remaining 300,000 Ordinary Shares issued to each of them pursuant to this exercise before the fourth anniversary of issue on 23 March 2021 when they would otherwise have been entitled to do so in accordance with the 2017 Long Term Incentive Plan.

Furthermore, Graeme Spenceley, sold a further 300,000 Ordinary Shares previously held by him at a price of 152 pence per Ordinary Share, as set out in the below table.

 Director

Prior holding

Issue of Ordinary shares pursuant to exercise of Options

Sale of Ordinary Shares

(total)

Resultant holding of Ordinary Shares

Resultant holding as %age of enlarged Ordinary Share capital

Graeme Spenceley

827,040

600,000

600,000

827,040

0.4%

Barnaby Kent

1,976,980

600,000

300,000

2,276,980

1.0%

Ben Dorks

1,699,320

600,000

300,000

1,999,320

0.9%

Application has been made for the total of 1,800,000 new Ordinary Shares issued pursuant to the above exercises of Share Options, which will rank pari passu with existing Ordinary Shares, to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings will commence at 8:00am on or around 10 October 2018.

Following Admission, the total issued share capital of the Company will consist of 218,924,518 Ordinary Shares. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive Officer

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

Alice Lane (ECM)

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit, Pentana Performance and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 3,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Graeme Spenceley

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Exercise of options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

1 pence

600,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

Off market transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Graeme Spenceley

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

152 pence

600,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

On market transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Barnaby Kent

2.

Reason for the notification

a)

Position/status:

Chief Operating Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Exercise of options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

1 pence

600,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

Off market transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Barnaby Kent

2.

Reason for the notification

a)

Position/status:

Chief Operating Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

152 pence

300,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

On market transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ben Dorks

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Exercise of options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

1 pence

600,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

Off market transaction

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ben Dorks

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ideagen plc

b)

LEI:

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

GB00B0CM0C50

b)

Nature of the transaction:

Sale of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

152 pence

300,000

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

4 October 2018

f)

Place of the transaction:

On market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMIBFTMBJMBFP
Date   Source Headline
8th Jul 20227:00 amRNSCancellation - Ideagen Plc
8th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
7th Jul 20223:45 pmRNSHolding(s) in Company
7th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
7th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
7th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
7th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
7th Jul 20221:19 pmGNWForm 8.3 - Ideagen PLC
7th Jul 202211:21 amRNSForm 8.3 - Ideagen plc
7th Jul 202210:39 amRNSForm 8.5 (EPT/RI)
7th Jul 20229:08 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
7th Jul 20227:30 amRNSSuspension – Ideagen PLC
7th Jul 20227:00 amRNSHolding(s) in Company
7th Jul 20227:00 amRNSScheme becomes Effective
6th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
6th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
6th Jul 20223:10 pmRNSHolding(s) in Company
6th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
6th Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
6th Jul 202211:41 amRNSForm 8.5 (EPT/RI)
6th Jul 202211:08 amGNWForm 8.3 - [IDEAGEN PLC - 05 07 2022] - (CGWL)
6th Jul 202211:03 amRNSForm 8.3 - IDEAGEN PLC
6th Jul 20229:09 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20229:00 amRNSForm 8 (DD) - Ideagen plc
6th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
5th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
5th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
5th Jul 20222:30 pmRNSExercise of Options, Issue of Equity and Rule 2.9
5th Jul 20222:20 pmRNSCourt Sanction of Scheme of Arrangement
5th Jul 202212:24 pmGNWForm 8.3 - [IDEAGEN PLC 04 07 2022] - (CGWL)
5th Jul 202212:13 pmRNSDisclosure under Rule 26
5th Jul 202212:10 pmRNSForm 8.3 - Ideagen plc
5th Jul 202210:58 amRNSForm 8.5 (EPT/RI)
5th Jul 20228:13 amRNSForm 8.5 (EPT/RI)
4th Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
4th Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
4th Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
4th Jul 20222:30 pmRNSHolding(s) in Company
4th Jul 202212:07 pmRNSForm 8.3 - Ideagen plc
4th Jul 202210:55 amRNSForm 8.5 (EPT/RI)
4th Jul 202210:47 amGNWForm 8.3 - [IDEAGEN PLC - 01 07 2022] - (CGWL)
4th Jul 20227:00 amBUSForm 8.3 - Ideagen PLC
1st Jul 20223:30 pmGNWForm 8.3 - Ideagen plc
1st Jul 20223:20 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:11 pmGNWForm 8.3 - [Ideagen plc - 30 06 2022] - (CGWL)
1st Jul 20223:09 pmRNSForm 8.3 - Ideagen plc
1st Jul 20223:00 pmRNSForm 8.3 - Ideagen PLC
1st Jul 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
1st Jul 202212:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.